News Details
07/05/2025 11:36
Bafna Pharmaceutical - Disclosure under SEBI Takeover Regulations
SRJR LIFESCIENCES LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.